Nancy Miller-rich - Net Worth and Insider Trading

Nancy Miller-rich Net Worth

The estimated net worth of Nancy Miller-rich is at least $4,389 dollars as of 2024-11-13. Nancy Miller-rich is the Director of Aldeyra Therapeutics Inc and owns about 922 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $4,389. Details can be seen in Nancy Miller-rich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nancy Miller-rich has not made any transactions after 2023-04-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Nancy Miller-rich

To

Nancy Miller-rich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nancy Miller-rich owns 4 companies in total, including Kadmon Holdings Inc (KDMN) , Aldeyra Therapeutics Inc (ALDX) , and Intercept Pharmaceuticals Inc (ICPT) among others .

Click here to see the complete history of Nancy Miller-rich’s form 4 insider trades.

Insider Ownership Summary of Nancy Miller-rich

Ticker Comapny Transaction Date Type of Owner
KDMN Kadmon Holdings Inc 2020-08-13 director
ALDX Aldeyra Therapeutics Inc 2023-04-12 director
ICPT Intercept Pharmaceuticals Inc 2020-05-28 director
LIMIT LIMIT 2020-12-10 director

Nancy Miller-rich Latest Holdings Summary

Nancy Miller-rich currently owns a total of 1 stock. Nancy Miller-rich owns 922 shares of Aldeyra Therapeutics Inc (ALDX) as of April 12, 2023, with a value of $4,389.

Latest Holdings of Nancy Miller-rich

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALDX Aldeyra Therapeutics Inc 2023-04-12 922 4.76 4,389

Holding Weightings of Nancy Miller-rich


Nancy Miller-rich Form 4 Trading Tracker

According to the SEC Form 4 filings, Nancy Miller-rich has made a total of 1 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 922 shares on April 12, 2023, which cost Nancy Miller-rich around $10,446.

Insider Trading History of Nancy Miller-rich

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nancy Miller-rich Trading Performance

GuruFocus tracks the stock performance after each of Nancy Miller-rich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nancy Miller-rich is -21.26%. GuruFocus also compares Nancy Miller-rich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nancy Miller-rich within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nancy Miller-rich's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nancy Miller-rich

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.91 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Nancy Miller-rich Ownership Network

Ownership Network List of Nancy Miller-rich

No Data

Ownership Network Relation of Nancy Miller-rich

Insider Network Chart

Nancy Miller-rich Owned Company Details

What does Kadmon Holdings Inc do?

Who are the key executives at Kadmon Holdings Inc?

Nancy Miller-rich is the director of Kadmon Holdings Inc. Other key executives at Kadmon Holdings Inc include director & President & CEO Harlan Waksal , Executive Vice President & CMO John L Ryan , and EVP & Chief Financial Officer Steven Meehan .

Kadmon Holdings Inc (KDMN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kadmon Holdings Inc (KDMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kadmon Holdings Inc (KDMN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kadmon Holdings Inc (KDMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kadmon Holdings Inc Insider Transactions

No Available Data

Nancy Miller-rich Mailing Address

Above is the net worth, insider trading, and ownership report for Nancy Miller-rich. You might contact Nancy Miller-rich via mailing address: C/o Intercept Pharmaceuticals, Inc., 10 Hudson Yards, 37th Fl, New York Ny 10001.